Cell & Gene Therapy Manufacturing & Commercialization Europe is dedicated to latest initiatives implemented by Cell Therapy production including:
- Taking an ATMP from Academia to Commercialisation
- Scale-Up Considerations for Cell Therapies
- Gene Therapy Development, Production and Commercialisation:
- Market opportunities and regulatory challenges in gene therapy
- GMP, production and scale-up challenges
- Future of cell therapy manufacturing and prioritising the resources
- Scientific Advice for ATMPs
- Characterising ATMPs: Developing Potency Assays and Performing Comparability Studies
Cell & Gene Therapy Manufacturing & Commercialization Europe might be held in 2024.
